NPR Health - Shots
NOVEMBER 12, 2022
The group Swayam Shikshan Prayog, which will be recognized today at the U.N. COP27 summit, focuses on the restoration of livelihoods, especially for women, amid the negative impacts of climate change.
Medical Xpress
NOVEMBER 12, 2022
A toddler is thriving after doctors in the U.S. and Canada used a novel technique to treat her before she was born for a rare genetic disease that caused the deaths of two of her sisters.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NPR Health - Shots
NOVEMBER 12, 2022
The war has hammered Ukraine's health care budget, leaving some patients without access to care. U.S. hospitals are helping to fill the gap.
Medical Xpress
NOVEMBER 12, 2022
Everyone in a district of 1.8 million people in China's southern metropolis of Guangzhou was ordered to stay home Saturday to undergo virus testing and a major city in the southwest closed schools as another rise in infections was reported.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
NPR Health - Shots
NOVEMBER 12, 2022
A recent study in the journal Scientific Reports found that hearing or seeing birds can have a positive benefit on one's mental health.
Medical Xpress
NOVEMBER 12, 2022
Tyrosine kinases are enzymes that play central roles in signaling by cytokines involved in the pathogenesis of autoimmune diseases, including lupus. A recent phase 2 clinical trial published in Arthritis & Rheumatology has generated promising results for deucravacitinib, an oral inhibitor of tyrosine kinase 2 (TYK2), in patients with active lupus.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Medical Xpress
NOVEMBER 12, 2022
Type I interferon (IFN) is a powerful immune activator that is present at high levels in the majority of patients with lupus, an autoimmune disease. In Arthritis & Rheumatology, researchers report positive results from the first placebo-controlled long-term trial of anifrolumab—a human monoclonal antibody that targets the type I IFN receptor—in patients with lupus.
Drug Patent Watch
NOVEMBER 12, 2022
[
Medical Xpress
NOVEMBER 12, 2022
Results from a recent clinical trial published by Wiley in Arthritis & Rheumatology demonstrate that patients with knee osteoarthritis experience short term pain relief from genicular nerve blocks—or locally injected anesthetics that block nerves around the knee joint.
Drug Patent Watch
NOVEMBER 12, 2022
OCALIVA (obeticholic acid) Intercept pharms inc Patent: 7,138,390 Expiration: Nov 16, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…. The post Drug Patent Expirations for the Week of November 13, 2022 appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Medical Xpress
NOVEMBER 12, 2022
A study at Hospital for Special Surgery (HSS) highlights the success of a lupus peer support and education group that transitioned to a virtual format during the pandemic. In addition to receiving high marks from group members, participation more than doubled after the meetings went remote.
Drug Patent Watch
NOVEMBER 12, 2022
This chart shows the pharmaceutical companies with the most patents in Cyprus. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Cyprus? appeared first on DrugPatentWatch - Make Better Decisions.
Expert insights. Personalized for you.
128 
Let's personalize your content